Cited by 68Metabolism, Diabetes, and CancerNitric Oxide and Endothelin EffectsAtherosclerosis and Cardiovascular Diseases

The AMP-Activated Protein Kinase Plays a Role in Antioxidant Defense and Regulation of Vascular Inflammation

Open access
Jansen, Thomas, Kvandová, Miroslava, Daiber, Andreas, Stamm, Paul, Frenis, Katie, Schulz, Eberhard, Münzel, Thomas, Kröller-Schön, Swenja·2020·Antioxidants

Abstract

Cardiovascular diseases represent the leading cause of global deaths and life years spent with a severe disability. Endothelial dysfunction and vascular oxidative stress are early precursors of atherosclerotic processes in the vascular wall, all of which are hallmarks in the development of cardiovascular diseases and predictors of future cardiovascular events. There is growing evidence that inflammatory processes represent a major trigger for endothelial dysfunction, vascular oxidative stress and atherosclerosis and clinical data identified inflammation as a cardiovascular risk factor on its own. AMP-activated protein kinase (AMPK) is a central enzyme of cellular energy balance and metabolism that has been shown to confer cardio-protection and antioxidant defense which thereby contributes to vascular health. Interestingly, AMPK is also redox-regulated itself. We have previously shown that AMPK largely contributes to a healthy endothelium, confers potent antioxidant effects and prevents arterial hypertension. Recently, we provided deep mechanistic insights into the role of AMPK in cardiovascular protection and redox homeostasis by studies on arterial hypertension in endothelial and myelomonocytic cell-specific AMPK knockout (Cadh5CrexAMPKfl/fl and LysMCrexAMPKfl/fl) mice. Using these cell-specific knockout mice, we revealed the potent anti-inflammatory properties of AMPK representing the molecular basis of the antihypertensive effects of AMPK. Here, we discuss our own findings in the context of literature data with respect to the anti-inflammatory and antioxidant effects of AMPK in the specific setting of arterial hypertension as well as cardiovascular diseases in general.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antiox9060525

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMPK has potent anti-inflammatory properties in hypertension.

    “Recently, deep mechanistic studies into the cardiovascular protection of AMPK using endothelial or myelomonocytic cell-specific AMPK KO mice have revealed the potent anti-inflammatory properties of AMPK in hypertension [145].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [145]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

3 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jansen, T., Kvandová, M., Daiber, A., Stamm, P., Frenis, K., Schulz, E., Münzel, T., & Kröller-Schön, S.
Affiliations
  • Johannes Gutenberg University Mainz (DE)
  • Allgemeines Krankenhaus Celle (DE)
  • Center for Cardiology, Department of Cardiology 1—Molecular Cardiology, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany
Corresponding author
Daiber, Andreas
Venue
Antioxidants
Publisher
MDPI AG
Published
2020-06-16
Volume
9
Issue
6
Pages
525
ISSN
2076-3921 (ISSN-L)
OpenAlex
W3034715300
Cited by
68
References
111
Citations by year
2026: 6 · 2025: 13 · 2024: 10 · 2023: 11 · 2022: 16 · 2021: 8 · 2020: 4
FWCI
0.93
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Deutsche Forschungsgemeinschaft (SCHU 1486/4-1)
  • Deutsches Zentrum für Herz-Kreislaufforschung (Partner Site Rhine-Main, Mainz, Germany)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
AMPK, antioxidant defense, vascular inflammation, endothelial dysfunction, vascular oxidative stress, atherosclerosis, hypertension, redox homeostasis, anti-inflammatory activity, cardioprotection, myelomonocytic cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review